Skip to Main Content

Author Details

Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
1994
365
66
PMIDPaper TitleJournal TitlePublished Year
35166264A Nationwide Prospective Clinical Trial on Active Surveillance in Patients With Non-intraabdominal Desmoid-type Fibromatosis: The GRAFITI Trial.Ann Surg2023
37701038Combatting the rising costs of cancer drugs; interventions from a university hospital's perspective.Front Pharmacol2023
37686693Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling.Cancers (Basel)2023
37968696Integrative whole-genome and transcriptome analysis of HER2-amplified metastatic breast cancer.Breast Cancer Res2023
37119048Physical symptom burden in patients with desmoid-type fibromatosis and its impact on health-related quality of life and healthcare use.Cancer Med2023
37452019Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival.NPJ Breast Cancer2023
37246093Local treatment in metastatic GIST patients: A multicentre analysis from the Dutch GIST Registry.Eur J Surg Oncol2023
37400554The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies.Sci Rep2023
37226020Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer.Breast Cancer Res Treat2023
36621142Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumors.Biomed Pharmacother2023
36900167Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting.Cancers (Basel)2023
36727954Health-related Quality of Life of Patients With Non-Intra-abdominal Desmoid-Type Fibromatosis During Active Surveillance: Results of a Prospective Observational Study.Ann Surg2023
36127572Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort.Cancer Med2023
34560242Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol2022
35740642Unraveling Desmoid-Type Fibromatosis-Specific Health-Related Quality of Life: Who Is at Risk for Poor Outcomes.Cancers (Basel)2022
35401025Prognostic Significance of Bone Metastasis in Soft Tissue Sarcoma Patients Receiving Palliative Systemic Therapy: An Explorative, Retrospective Pooled Analysis of the EORTC-Soft Tissue and Bone Sarcoma Group (STBSG) Database.Sarcoma2022
35606463Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing.Br J Cancer2022
35366566Validity and utility of HER2/ERBB2 copy number variation assessed in liquid biopsies from breast cancer patients: A systematic review.Cancer Treat Rev2022
35628441<i>ESR1</i> Methylation Measured in Cell-Free DNA to Evaluate Endocrine Resistance in Metastatic Breast Cancer Patients.Int J Mol Sci2022
35567919First-in-man, first-in-class phase I study with the monopolar spindle 1 kinase inhibitor S81694 administered intravenously in adult patients with advanced, metastatic solid tumours.Eur J Cancer2022
36455584Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab.Lancet Oncol2022
36017997Physicians' Perspectives on Ethical Issues Regarding Expensive Anti-Cancer Treatments: A Qualitative Study.AJOB Empir Bioeth2022
36323051CABA-V7: a prospective biomarker selected trial of cabazitaxel treatment in AR-V7 positive prostate cancer patients.Eur J Cancer2022
36077836Intratumoral Niches of B Cells and Follicular Helper T Cells, and the Absence of Regulatory T Cells, Associate with Longer Survival in Early-Stage Oral Tongue Cancer Patients.Cancers (Basel)2022
35158976Development of a Disease-Specific Health-Related Quality of Life Questionnaire (DTF-QoL) for Patients with Desmoid-Type Fibromatosis.Cancers (Basel)2022
35221159In desmoid-type fibromatosis cells sorafenib induces ferroptosis and apoptosis, which are enhanced by autophagy inhibition.Eur J Surg Oncol2022
35248823Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.ESMO Open2022
35151276The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer.BMC Cancer2022
34878805Prognostic Value of Circulating Tumor Cell Characteristics May Be Biased by Their Quantity.J Clin Oncol2022
35088185Differential Diagnosis and Molecular Stratification of Gastrointestinal Stromal Tumors on CT Images Using a Radiomics Approach.J Digit Imaging2022
34964258A pipeline for copy number profiling of single circulating tumour cells to assess intrapatient tumour heterogeneity.Mol Oncol2022
35050709Apolipoprotein B mRNA-Editing Catalytic Polypeptide-Like-Induced Protein Changes in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Throughout Disease Progression.JCO Precis Oncol2022
32949099Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients.Mol Oncol2021
33765967Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.BMC Cancer2021
33514525Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases.Clin Cancer Res2021
33761899Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer.BMC Cancer2021
33643695B-cell clusters at the invasive margin associate with longer survival in early-stage oral-tongue cancer patients.Oncoimmunology2021
33920135A Systematic Review of the Use of Circulating Cell-Free DNA Dynamics to Monitor Response to Treatment in Metastatic Breast Cancer Patients.Cancers (Basel)2021
33915880The <i>BRAF</i> P.V600E Mutation Status of Melanoma Lung Metastases Cannot Be Discriminated on Computed Tomography by LIDC Criteria nor Radiomics Using Machine Learning.J Pers Med2021
33495476Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features.Nat Commun2021
34500044Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.Ann Oncol2021
34555650Adjuvant treatment in patients with melanoma: The planning of scanning.Eur J Cancer2021
34670587High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.Clin Epigenetics2021
34781194Cost-effectiveness of adjuvant systemic therapies for patients with high-risk melanoma in Europe: a model-based economic evaluation.ESMO Open2021
34303806Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>â¿¿</sup>.Ann Oncol2021
34326338The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets.Nat Commun2021
34249756Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients.Front Oncol2021
34039979Author Correction: Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features.Nat Commun2021
33932725Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.Eur J Cancer2021
34206149The Evaluation of Health-Related Quality of Life Issues Experienced by Patients with Desmoid-Type Fibromatosis (The QUALIFIED Study)-A Protocol for an International Cohort Study.Cancers (Basel)2021
  • 1 - 50 of 365

Recommended Authors

University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 4
Crown Princess Mary Cancer Centre, Westmead Hospital
Career Start Year 2008
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 2
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 2
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 4
HM Hospitales-Centro Integral Oncologico Clara Campal
Career Start Year 2001
Number of shared co-authors 2
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 7
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 2
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 1
The Kinghorn Cancer Centre, St. Vincent's Hospital Sydney
Career Start Year 1997
Number of shared co-authors 4
New York Presbyterian Hospital
Career Start Year 1997
Number of shared co-authors 0
Hospital HM Universitario Sanchinarro
Career Start Year 1997
Number of shared co-authors 0
University of Milan
Career Start Year 1996
Number of shared co-authors 9
University of California Davis Comprehensive Cancer Center
Career Start Year 1996
Number of shared co-authors 3
Stanford University
Career Start Year 1996
Number of shared co-authors 0
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 6
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 4
Olivia Newton-John Cancer Research Institute
Career Start Year 1993
Number of shared co-authors 3
Merck & Co., Inc.
Career Start Year 1991
Number of shared co-authors 1
Odette Cancer Centre
Career Start Year 1991
Number of shared co-authors 5
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 6
Lehigh Valley Topper Cancer Institute
Career Start Year 1990
Number of shared co-authors 3
Hospital del Mar Research Institute
Career Start Year 1990
Number of shared co-authors 2
Institut Curie
Career Start Year 1990
Number of shared co-authors 9
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 5
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 3
University of Bern
Career Start Year 1985
Number of shared co-authors 7
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 5
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 2

Collaborators

Erasmus Medical Center (MC) Cancer Institute
Co-authored papers 78
Erasmus MC Cancer Institute
Co-authored papers 32
Franciscus Gasthuis & Vlietland Hospital Rotterdam and Schiedam
Co-authored papers 28
Netherlands Cancer Institute-Antoni Van Leeuwenhoek
Co-authored papers 27
The Netherlands Cancer Institute
Co-authored papers 19
Erasmus MC Cancer Institute
Co-authored papers 16
Erasmus Medical Center
Co-authored papers 14
Hartwig Medical Foundation
Co-authored papers 14
Center for Statistics, Hasselt University
Co-authored papers 14
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Co-authored papers 13
Department of Pharmaceutical Sciences, Utrecht University
Co-authored papers 9
Co-authored papers 8
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Co-authored papers 8
Erasmus MC Cancer Institute
Co-authored papers 8
University Claude Bernard Lyon I
Co-authored papers 6
Erasmus MC Cancer Institute
Co-authored papers 6
Erasmus MC Cancer Institute
Co-authored papers 6
Department of Immunology Erasmus University Medical Center
Co-authored papers 6
Erasmus MC Cancer Institute, University Medical Center
Co-authored papers 6
University College London Hospitals NHS Foundation Trust
Co-authored papers 5
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 5
Co-authored papers 4
Fondazione IRCSS Istituto Nazionale dei Tumori
Co-authored papers 3
Oslo University Hospital
Co-authored papers 3
Royal Manchester Children's Hospital
Co-authored papers 3
Medical University of Graz
Co-authored papers 3
Erasmus University Medical Center
Co-authored papers 3
Cancer Center Amsterdam
Co-authored papers 3
University College London, Cancer Institute
Co-authored papers 2
Ohio State University
Co-authored papers 2